Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024

April 18, 2024

https://www.globenewswire.com/news-release/2024/04/18/2865850/0/en/Celularity-Abstract-Emerging-Technologies-for-the-Management-and-Protection-of-Tendon-Injuries-Decellularized-Placental-Biomaterials-Accepted-at-ORS-Tendon-Conference-2024.html

FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq:CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that its abstract entitled “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” was accepted by the Orthopedic Research Society (ORS) Tendon Conference, which will be held from May 30 – June 1, 2024 at the Mayo Clinic in Rochester, MN. The conference theme is “Mechanism to Therapy – Emerging Technologies and Therapeutic Outcomes.”

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.